Prospera Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.71M Sell
26,804
-845
-3% -$289K 0.14% 160
2026
Q1
$9.73M Sell
27,649
-877
-3% -$313K 0.16% 147
2025
Q4
$9.34M Buy
28,526
+966
+4% +$306K 0.15% 143
2025
Q3
$7.78M Sell
27,560
-6,723
-20% -$1.95M 0.13% 164
2025
Q2
$9.58M Buy
34,283
+1,899
+6% +$538K 0.18% 128
2025
Q1
$10.1M Sell
32,384
-179
-0.5% -$52.9K 0.23% 99
2024
Q4
$8.49M Buy
32,563
+2,190
+7% +$650K 0.2% 118
2024
Q3
$9.79M Buy
30,373
+6,662
+28% +$2.18M 0.25% 86
2024
Q2
$7.41M Sell
23,711
-2,626
-10% -$771K 0.21% 105
2024
Q1
$7.49M Sell
26,337
-450
-2% -$132K 0.22% 96
2023
Q4
$7.72M Buy
26,787
+511
+2% +$139K 0.26% 86
2023
Q3
$7.06M Sell
26,276
-510
-2% -$127K 0.27% 77
2023
Q2
$5.95M Buy
26,786
+1,284
+5% +$298K 0.23% 108
2023
Q1
$6.17M Buy
25,502
+11,105
+77% +$2.73M 0.25% 98
2022
Q4
$3.78M Sell
14,397
-6,807
-32% -$1.82M 0.19% 124
2022
Q3
$4.78M Buy
21,204
+406
+2% +$98.4K 0.25% 95
2022
Q2
$5.06M Sell
20,798
-111
-0.5% -$27.2K 0.26% 84
2022
Q1
$5.06M Buy
20,909
+2,278
+12% +$523K 0.21% 108
2021
Q4
$4.19M Buy
18,631
+2,403
+15% +$507K 0.18% 129
2021
Q3
$3.45M Sell
16,228
-5,814
-26% -$1.34M 0.17% 155
2021
Q2
$5.37M Buy
22,042
+239
+1% +$58.8K 0.27% 89
2021
Q1
$5.42M Buy
21,803
+6,143
+39% +$1.47M 0.32% 64
2020
Q4
$3.6M Buy
15,660
+13,944
+813% +$3.21M 0.25% 89
2020
Q3
$436K Sell
1,716
-13,016
-88% -$3.22M 0.17% 112
2020
Q2
$3.47M Buy
14,732
+819
+6% +$187K 0.31% 77
2020
Q1
$2.82M Buy
13,913
+1,612
+13% +$352K 0.3% 70
2019
Q4
$2.96M Buy
12,301
+7,486
+155% +$1.65M 0.23% 100
2019
Q3
$932K Buy
4,815
+446
+10% +$85.6K 0.1% 189
2019
Q2
$809K Buy
4,369
+681
+18% +$122K 0.09% 193
2019
Q1
$716K Buy
3,688
+1,075
+41% +$205K 0.24% 122
2018
Q4
$510K Sell
2,613
-230
-8% -$44.9K 0.1% 194
2018
Q3
$566K Buy
2,843
+221
+8% +$43.6K 0.11% 195
2018
Q2
$488K Sell
2,622
-590
-18% -$104K 0.07% 236
2018
Q1
$553K Buy
3,212
+991
+45% +$182K 0.08% 219
2017
Q4
$394K Sell
2,221
-679
-23% -$120K 0.06% 262
2017
Q3
$543K Buy
2,900
+314
+12% +$55.6K 0.08% 220
2017
Q2
$445K Sell
2,586
-243
-9% -$39.5K 0.07% 237
2017
Q1
$462K Buy
2,829
+758
+37% +$126K 0.08% 200
2016
Q4
$309K Sell
2,071
-1,486
-42% -$224K 0.06% 264
2016
Q3
$594K Buy
3,557
+848
+31% +$143K 0.12% 160
2016
Q2
$412K Buy
2,709
+618
+30% +$96.1K 0.09% 198
2016
Q1
$321K Buy
+2,091
New +$311K 0.07% 207
2015
Q1
Sell
-1,558
Closed -$248K 321
2014
Q4
$248K Sell
1,558
-623
-29% -$97.1K 0.06% 236
2014
Q3
$208K Buy
+2,181
New +$285K 0.06% 256

Other funds holding AMGN

Prospera Financial Services's AMGN Position: Q2 2026 in Review

Prospera Financial Services reduced its Amgen (AMGN) stake by 3.1% in Q2 2026, selling an estimated $289K and leaving 26,804 shares worth $9.71M. The position accounts for 0.14% of the portfolio, ranked #160.

Prospera Financial Services first reported a position in AMGN in Q3 2014 and has held it in 44 quarters since. The position peaked at $10.1M in Q1 2025. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Prospera Financial Services held 26,804 shares of Amgen worth $9.71M as of Q2 2026.
  • Prospera Financial Services sold 845 Amgen shares in Q2 2026, an estimated $289K.
  • Amgen made up 0.14% of Prospera Financial Services's portfolio in Q2 2026, its #160 holding.
  • Prospera Financial Services first reported a position in Amgen in Q3 2014 and has held it in 44 quarters since.
  • Prospera Financial Services's Amgen position peaked at $10.1M in Q1 2025.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.